Total Payments
$2,561
2024 Payments
$1,611
Companies
13
Transactions
35
Medicare Patients
7,672
Medicare Billing
$1.2M
Payment Breakdown by Category
Travel$1,495 (58.4%)
Food & Beverage$1,066 (41.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Travel and Lodging | $1,495 | 7 | 58.4% |
| Food and Beverage | $1,066 | 28 | 41.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $981.83 | 9 | $0 (2024) |
| Philips North America LLC | $615.60 | 2 | $0 (2024) |
| Esperion Therapeutics, Inc. | $423.01 | 3 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $194.19 | 9 | $0 (2022) |
| HeartFlow, Inc. | $144.94 | 1 | $0 (2023) |
| Kowa Pharmaceuticals America, Inc. | $60.40 | 4 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $31.25 | 1 | $0 (2019) |
| Amarin Pharma Inc. | $23.08 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $23.03 | 1 | $0 (2019) |
| Philips Electronics North America Corporation | $19.57 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,611 | 12 | Abbott Laboratories ($981.83) |
| 2023 | $189.37 | 4 | HeartFlow, Inc. ($144.94) |
| 2022 | $83.20 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($47.66) |
| 2021 | $592.62 | 11 | Esperion Therapeutics, Inc. ($423.01) |
| 2019 | $54.28 | 2 | AstraZeneca Pharmaceuticals LP ($31.25) |
| 2018 | $30.56 | 2 | NOVARTIS PHARMACEUTICALS CORPORATION ($17.33) |
All Payment Transactions
35 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $495.79 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $60.16 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $21.21 | General |
| Category: Structural Heart | ||||||
| 12/20/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $9.02 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Travel and Lodging | In-kind items and services | $292.86 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $32.18 | General |
| Category: Structural Heart | ||||||
| 12/19/2024 | Abbott Laboratories | — | Food and Beverage | In-kind items and services | $6.25 | General |
| Category: Structural Heart | ||||||
| 04/03/2024 | ABBVIE INC. | LINZESS (Drug), CREON | Food and Beverage | In-kind items and services | $13.59 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/25/2024 | Philips North America LLC | (9525) Intracardiac Und (Device) | Travel and Lodging | In-kind items and services | $319.20 | General |
| Category: Medical Device | ||||||
| 02/25/2024 | Philips North America LLC | (9525) Intracardiac Und (Device) | Travel and Lodging | In-kind items and services | $296.40 | General |
| Category: Medical Device | ||||||
| 11/15/2023 | HeartFlow, Inc. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $144.94 | General |
| Category: Coronary | ||||||
| 11/13/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: CARDIOVASCULAR | ||||||
| 10/16/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $14.36 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/22/2023 | Kowa Pharmaceuticals America, Inc. | LIVALO (Drug) | Food and Beverage | In-kind items and services | $15.08 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/20/2022 | Kowa Pharmaceuticals America, Inc. | Livalo (Drug) | Food and Beverage | Cash or cash equivalent | $15.97 | General |
| Category: Cardiovascular | ||||||
| 10/24/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $19.57 | General |
| Category: Medical Device | ||||||
| 03/11/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: DIABETES | ||||||
| 01/25/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: DIABETES | ||||||
| 12/28/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $21.81 | General |
| Category: DIABETES | ||||||
| 12/07/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/10/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $29.64 | General |
| Category: DIABETES | ||||||
| 11/09/2021 | Esperion Therapeutics, Inc. | NEXLIZET (Drug), NEXLETOL | Food and Beverage | In-kind items and services | $150.00 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 11/05/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $34.49 | General |
| Category: DIABETES | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 23 | 2,174 | 2,907 | $2.2M | $328,042 |
| 2022 | 17 | 1,544 | 2,090 | $1.5M | $235,450 |
| 2021 | 22 | 2,102 | 2,776 | $2.0M | $325,062 |
| 2020 | 21 | 1,852 | 2,679 | $1.9M | $315,736 |
Total Patients
7,672
Total Services
10,452
Medicare Billing
$1.2M
Procedure Codes
88
All Medicare Procedures & Services
88 procedure records from CMS Medicare Utilization — Page 2 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 285 | 287 | $502,250 | $48,471 | 9.7% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2022 | 188 | 363 | $90,750 | $34,254 | 37.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 288 | 293 | $102,550 | $17,374 | 16.9% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2022 | 89 | 356 | $76,540 | $15,952 | 20.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 76 | 115 | $43,095 | $11,553 | 26.8% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2022 | 188 | 188 | $84,600 | $10,879 | 12.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 30 | 71 | $24,050 | $6,582 | 27.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 26 | 34 | $22,100 | $6,053 | 27.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 17 | 17 | $11,350 | $3,303 | 29.1% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2022 | 19 | 19 | $9,901 | $1,734 | 17.5% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Facility | 2022 | 14 | 14 | $3,850 | $805.32 | 20.9% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2022 | 27 | 29 | $4,060 | $627.05 | 15.4% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2022 | 19 | 19 | $1,710 | $301.12 | 17.6% |
| J0280 | Injection, aminophyllin, up to 250 mg | Office | 2022 | 25 | 25 | $625.00 | $143.32 | 22.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 31 | 37 | $1,295 | $109.71 | 8.5% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2022 | 15 | 16 | $640.00 | $104.94 | 16.4% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2022 | 29 | 29 | $580.00 | $77.90 | 13.4% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Office | 2021 | 465 | 467 | $817,250 | $87,523 | 10.7% |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | Office | 2021 | 178 | 178 | $535,780 | $82,512 | 15.4% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2021 | 206 | 382 | $95,500 | $38,792 | 40.6% |
| 93306 | Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | Facility | 2021 | 439 | 454 | $158,900 | $28,617 | 18.0% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2021 | 124 | 496 | $106,640 | $22,767 | 21.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 81 | 126 | $42,840 | $14,137 | 33.0% |
| 93015 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report | Office | 2021 | 207 | 207 | $93,150 | $12,247 | 13.1% |
| 78451 | Nuclear medicine study of vessels of heart using drugs or exercise single study | Office | 2021 | 30 | 30 | $45,000 | $9,842 | 21.9% |
About Jennifer Chen
Jennifer Chen is a Nuclear Cardiology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/19/2010. The National Provider Identifier (NPI) number assigned to this provider is 1982920716.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jennifer Chen has received a total of $2,561 in payments from pharmaceutical and medical device companies, with $1,611 received in 2024. These payments were reported across 35 transactions from 13 companies. The most common payment nature is "Travel and Lodging" ($1,495).
As a Medicare-enrolled provider, Chen has provided services to 7,672 Medicare beneficiaries, totaling 10,452 services with total Medicare billing of $1.2M. Data is available for 4 years (2020–2023), covering 88 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location New York, NY
- Active Since 04/19/2010
- Last Updated 01/28/2021
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1982920716
Products in Payments
- (9525) Intracardiac Und (Device) $615.60
- NEXLIZET (Drug) $423.01
- JARDIANCE (Drug) $194.19
- FFRct (Device) $144.94
- LIVALO (Drug) $44.43
- BRILINTA (Drug) $31.25
- Vascepa (Drug) $23.08
- ELIQUIS (Drug) $23.03
- (5044) MCOT (Device) $19.57
- PAZEO (Drug) $17.33
- Livalo (Drug) $15.97
- LINZESS (Drug) $13.59
- CARDIOGEN (Drug) $13.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nuclear Cardiology Doctors in New York
Dr. Klaus Rentrop, M.d, M.D
Nuclear Cardiology — Payments: $11.7M
Nuclear Cardiology $11.7M
Samuel Kim
Nuclear Cardiology — Payments: $6,833
Nuclear Cardiology $6,833
Dr. Saaron Laighold, M.d, M.D
Nuclear Cardiology — Payments: $3,519
Nuclear Cardiology $3,519
David Bolon
Nuclear Cardiology — Payments: $1,757
Nuclear Cardiology $1,757
Dr. Marc Nolan, M.d, M.D
Nuclear Cardiology — Payments: $1,751
Nuclear Cardiology $1,751
Stephen Mccullough, Md, MD
Nuclear Cardiology — Payments: $899.48
Nuclear Cardiology $899.48